The risk of stroke after thrombolytic therapy.

The risk of stroke after thrombolytic therapy.

Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke.

Stroke and cardiac papillary fibroelastoma: mechanical thrombectomy after thrombolytic therapy.

Decompressive craniectomy for stroke after intravenous thrombolytic therapy.

QT Dispersion after Thrombolytic Therapy.

Influence of racial differences on outcomes after thrombolytic therapy in acute ischemic stroke.

Stroke complicating thrombolytic therapy of acute myocardial infarction.

Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke.

Predictive factors for early clinical improvement after intra-arterial thrombolytic therapy in acute ischemic stroke.

Is renal dysfunction associated with adverse stroke outcome after thrombolytic therapy?

Clinical Outcome in Acute Ischemic Stroke Patients With Microbleeds After Thrombolytic Therapy: A Meta-Analysis.

Haematuria and proteinuria after thrombolytic therapy.

Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke.

Risk index and thrombolytic treatment in acute ischemic stroke--reply.

Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.

Progress in Intravenous Thrombolytic Therapy for Acute Stroke.

Repeated thrombolytic therapy in patients with recurrent acute ischemic stroke.

Risk index and thrombolytic treatment in acute ischemic stroke.

Thrombolytic agents in the treatment of stroke.

Thrombolytic therapy.

Thrombolytic therapy.

Assessment of reperfusion after thrombolytic therapy for myocardial infarction.

Late potentials as predictors of risk after thrombolytic treatment?

Intracranial hemorrhage after thrombolytic therapy: a therapeutic conflict.

Suggest Documents

The risk of stroke after thrombolytic therapy.

Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke.

Stroke and cardiac papillary fibroelastoma: mechanical thrombectomy after thrombolytic therapy.

Decompressive craniectomy for stroke after intravenous thrombolytic therapy.

QT Dispersion after Thrombolytic Therapy.

Influence of racial differences on outcomes after thrombolytic therapy in acute ischemic stroke.

Stroke complicating thrombolytic therapy of acute myocardial infarction.

Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke.

Predictive factors for early clinical improvement after intra-arterial thrombolytic therapy in acute ischemic stroke.

Is renal dysfunction associated with adverse stroke outcome after thrombolytic therapy?

Clinical Outcome in Acute Ischemic Stroke Patients With Microbleeds After Thrombolytic Therapy: A Meta-Analysis.

Haematuria and proteinuria after thrombolytic therapy.

Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke.

Risk index and thrombolytic treatment in acute ischemic stroke--reply.

Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.

Progress in Intravenous Thrombolytic Therapy for Acute Stroke.

Repeated thrombolytic therapy in patients with recurrent acute ischemic stroke.

Risk index and thrombolytic treatment in acute ischemic stroke.

Thrombolytic agents in the treatment of stroke.

Thrombolytic therapy.

Thrombolytic therapy.

Assessment of reperfusion after thrombolytic therapy for myocardial infarction.

Late potentials as predictors of risk after thrombolytic treatment?

Intracranial hemorrhage after thrombolytic therapy: a therapeutic conflict.

The risk of stroke after thrombolytic therapy.

Recommend Documents

Follow Us